Differences in homing potentials of streptococcus pneumoniae-specific plasmablasts in pneumococcal pneumonia and after pneumococcal polysaccharide and pneumococcal conjugate vaccinations

Journal of Infectious Diseases

Volumn 212, Issue 8, 2015, Pages 1279-1287

  Palkola, Nina V ^a   Pakkanen, Sari H ^a   Kantele, Jussi M ^b   Pakarinen, Laura ^a   Puohiniemi, Ritvaleena ^a   Kantele, Anu ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

homing receptor; lymphocyte homing; mucosal immune response; PCV; pneumococcal conjugate vaccine; pneumococcal polysaccharide vaccine; pneumococcus; pneumonia; PPV; Streptococcus pneumoniae

Indexed keywords

CUTANEOUS LYMPHOCYTE ASSOCIATED ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; L SELECTIN; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS VACCINE; BACTERIUM ANTIBODY; POLYSACCHARIDE; VACCINE;

ADULT; ANTIBODY SECRETING CELL; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG EFFICACY; FEMALE; HUMAN; IMMUNE RESPONSE; MALE; NONHUMAN; PLASMABLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; VACCINATION; AGED; CYTOLOGY; IMMUNOLOGY; MIDDLE AGED; MUCOSAL IMMUNITY; PLASMA CELL; PNEUMONIA, PNEUMOCOCCAL; RESPIRATORY SYSTEM; YOUNG ADULT;

ADULT; AGED; ANTIBODIES, BACTERIAL; FEMALE; HUMANS; IMMUNITY, MUCOSAL; L-SELECTIN; MALE; MIDDLE AGED; PLASMA CELLS; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; POLYSACCHARIDES; RESPIRATORY SYSTEM; STREPTOCOCCUS PNEUMONIAE; VACCINATION; VACCINES, CONJUGATE; YOUNG ADULT;

EID: 84943412613     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv208     Document Type: Article

References (49)

1. Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis. 2004; 4: 144-54
2. Simell B, Auranen K, Käyhty H, Goldblatt D, Dagan R, Obrien KL. The fundamental link between pneumococcal carriage and disease. Expert Rev Vaccines. 2012; 11: 841-55
3. Twigg HL III. Humoral immune defense (antibodies): recent advances. Proc Am Thorac Soc. 2005; 2: 417-21
4. Goldblatt D, Hussain M, Andrews N, et al. Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study. J Infect Dis. 2005; 192: 387-93
5. Jambo KC, Sepako E, Heyderman RS, Gordon SB. Potential role for mucosally active vaccines against pneumococcal pneumonia. Trends Microbiol. 2010; 18: 81-9
6. Richards L, Ferreira DM, Miyaji EN, Andrew PW, Kadioglu A. The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease. Immunobiology. 2010; 215: 251-63
7. Sun K, Johansen F-E, Eckmann L, Metzger DW. An important role for polymeric Ig receptor-mediated transport of IgA in protection against Streptococcus pneumoniae nasopharyngeal carriage. J Immunol. 2004; 173: 4576-81
8. Ferreira DM, Darrieux M, Silva DA, et al. Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice. Clin Vaccine Immunol. 2009; 16: 636-45
9. Pitsiou GG, Kioumis IP. Pneumococcal vaccination in adults: Does it really work? Respir Med. 2011; 105: 1776-83
10. Moberley SA, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev. 2013; 1: CD000422
11. Ochoa-Gondar O, Vila-Corcoles A, Rodriguez-Blanco T, et al. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-Acquired pneumonia in the general population aged 60 years: 3 years of follow-up in the CAPAMIS study. Clin Infect Dis. 2014; 58: 909-17
12. von Gottberg A, de Gouveia L, Tempia S, et al. Effects of vaccination on invasive pneumococcal disease in South Africa. N Engl J Med. 2014; 371: 1889-99
13. Cutts FT, Zaman SMA, Enwere G, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomized, double-blind, placebo-controlled trial. Lancet. 2005; 365: 1139-46
14. Lucero MG, Dulalia VE, Nillos LT, et al. Pneumococcal conjugate vaccines for preventing vaccine-Type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age. Cochrane Database Syst Rev. 2009; 4: CD004977
15. Angoulvant F, Levy C, Grimprel E, et al. Early impact of 13-valent pneumococcal conjugate vaccine on community-Acquired pneumonia in children. Clin Infect Dis. 2014; 58: 918-24
16. Brandtzaeg P, Johansen FE. Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties. Immunol Rev. 2005; 206: 32-63
17. Sigmundsdottir H, Butcher EC. Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking. Nature Immunol. 2008; 9: 981-7
18. Camerini D, James SP, Stamenkovic I, Seed B. Leu-8/TQ1 is the human equivalent of the Mel-14 lymph node homing receptor. Nature. 1989; 342: 78-82
19. Berlin C, Berg EL, Briskin MJ, et al. α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell. 1993; 74: 185-95.17
20. Berg EL, Yoshino T, Rott LS, et al. The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1. J Exp Med. 1991; 174: 1461-6
21. Quiding-Järbrink M, Nordström I, Granström G, et al. Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations A molecular basis for the compartmentalization of effector B cell responses. J Clin Invest. 1997; 99: 1281-6
22. Kantele A, Kantele JM, Savilahti E, et al. Homing potentials of circulating lymphocytes in humans depend on the site of activation: oral, but not parenteral, typhoid vaccination induces circulating antibody-secreting cells that all bear homing receptors directing them to the gut. J Immunol. 1997; 158: 574-9
23. Kantele A, Häkkinen M, Moldoveanu Z, et al. Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: evidence for compartmentalization within the common mucosal immune system in humans. Infect Immun. 1998; 66: 5630-5
24. Sundström P, Lundin SB, Nilsson L-Å, Quiding-Järbrink M. Human IgA-secreting cells induced by intestinal, but not systemic, immunization respond to CCL25 (TECK) and CCL28 (MEC). Eur J Immunol. 2008; 38: 3327-38
25. Xu B, Wagner N, Pham LN, et al. Lymphocyte homing to bronchus-Associated lymphoid tissue (BALT) is mediated by L-selectin/PNAd, α4β1 integrin/VCAM-1, and LFA-1 adhesion pathways. J Exp Med. 2003; 197: 1255-67
26. Palkola NV, Pakkanen SH, Kantele JM, Rossi N, Puohimiemi R, Kantele A. Pathogen-specific circulating plasmablasts in patients with pneumonia. PLoS One. 2012; 7: e34334
27. Kantele A, Arvilommi H, Jokinen I. Specific immunoglobulin-secreting human blood cells after peroral vaccination against Salmonella typhi. J Infect Dis. 1986; 153: 1126-31
28. Kantele A. Antibody-secreting cells in the evaluation of the immunogenicity of an oral vaccine. Vaccine. 1990; 8: 321-6
29. Kantele JM, Arvilommi H, Kontiainen S, et al. Mucosally activated circulating human B cells in diarrhea express homing receptors directing them back to the gut. Gastroenterology. 1996; 110: 1061-7
30. Kantele AM, Takanen R, Arvilommi H. Immune response to acute diarrhea seen as circulating antibody-secreting cells. J Infect Dis. 1988; 158: 1011-6
31. Kantele A, Zivny J, Häkkinen M, Elson CO, Mestecky J. Differential homing commitments of antigen-specific T cells after oral or parenteral immunization in humans. J Immunol. 1999; 162: 5173-7
32. Kantele J, Kantele A, Arvilommi H. Circulating immunoglobulin-secreting cells are heterogeneous in their expression of maturation markers and homing receptors. Clin Exp Immunol. 1996; 104: 525-30
33. Weinberger DM, Dagan R, Givon-Lavi N, et al. Epidemiologic evidence for serotype-specific acquired immunity to pneumococcal carriage. J Infect Dis. 2008; 197: 1511-8
34. Musher DM, Groover JE, Reichler MR, et al. Emergence of antibody to capsular polysaccharides of Streptococcus pneumoniae during outbreaks of pneumonia: association with nasopharyngeal colonization. Clin Infect Dis. 1997; 24: 441-6
35. McEllistrem MC, Mendelsohn AB, Pass MA, et al. Recurrent invasive pneumococcal disease in individuals with human immunodeficiency virus infection. J Infect Dis. 2002; 185: 1364-8
36. Kawamata N, Xu B, Nishijima H, et al. Expression of endothelia and lymphocyte adhesion molecules in bronchus-Associated lymphoid tissue (BALT) in adult human lung. Respir Res. 2009; 10: 97
37. Walrath JR, Silver RF. The α4β1 integrin in localization of mycobacterium tuberculosis-specific T helper type 1 cells to the human lung. Am J Respir Cell Mol Biol. 2011; 45: 24-30
38. Abitorabi MA, Mackay CR, Jerome EH, Osorio O, Butcher EC, Erle DJ. Differential expression of homing molecules on recirculating lymphocytes from sheep gut, peripheral, and lung lymph. J Immunol. 1996; 156: 3111-7
39. Picker LJ, Martin RJ, Trumble A, et al. Differential expression of lymphocyte homing receptors by human memory/effector T cells in pulmonary versus cutaneous immune effector sites. Eur J Immunol. 1994; 24: 1269-77
40. Campbell JJ, Brightling CE, Symon FA, et al. Expression of chemokine receptors by lung T cells from normal and asthmatic subjects. J Immunol. 2001; 166: 2842-8
41. Abonia JP, Hallgren J, Jones T, et al. Alpha-4 integrins and VCAM-1, but not MAdCAM-1, are essential for recruitment of mast cell progenitors to the inflamed lung. Blood. 2006; 108: 1588-94
42. Kantele AM, Palkola NV, Arvilommi HS, Kantele JM. Distinctive homing profile of pathogen-specific activated lymphocytes in human urinary tract infection. Clin Immunol. 2008; 128: 427-34
43. Pakkanen SH, Kantele JM, Moldoveanu Z, et al. Expression of homing receptors on IgA1 and IgA2 plasmablasts in blood reflects differential distribution of IgA1 and IgA2 in various body fluids. Clin Vaccine Immunol. 2010; 17: 393-401
44. Kantele A, Arvilommi H, Iikkanen K, et al. Unique characteristics of the intestinal immune system as an inductive site after antigen reencounter. J Infect Dis. 2005; 191: 312-7
45. Kantele A, Savilahti E, Tiimonen H, Iikkanen K, Autio S, Kantele JM. Cutaneous lymphocyte antigen expression on human effector B cells depends on the site and on the nature of antigen encounter. Eur J Immunol. 2003; 33: 3275-83
46. Csencsits KL, Jutila MA, Pascual DW. MadCAM-1 in NALT endothelial venules in a mucosal site in naive lymphocyte adhesion to high primary role of peripheral node addressin phenotypic and functional evidence for the nasal-Associated lymphoid tissue. J Immunol. 1999; 163: 1382-9
47. Gordon SB, Miller DE, Day RB, et al. Pulmonary immunoglobulin responses to Streptococcus pneumoniae are altered but not reduced in human immunodeficiency virus-infected Malawian adults. J Infect Dis. 2003; 188: 666-70
48. Käyhty H, Auranen K, Nohynek H, Dagan R, Mäkelä PH; the Pneumococcal Carriage Group (PneumoCarr). Nasopharyngeal colonization: a target for pneumococcal vaccination. Expert Rev Vaccines. 2006; 5: 651-68
49. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001; 344: 403-9